These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 24295201)

  • 1. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
    Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
    Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review.
    Mansilla-Polo M; Morgado-Carrasco D
    Dermatol Ther (Heidelb); 2024 Jun; 14(6):1389-1442. PubMed ID: 38763966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?
    Uslu S
    Acta Endocrinol (Buchar); 2023; 19(3):376-379. PubMed ID: 38356986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis.
    Ruytinx P; Vandormael P; Quaden D; Luyten E; Geusens P; Vanhoof J; Agten A; Vandenabeele F; de Vlam K; Somers V
    Front Med (Lausanne); 2022; 9():1072453. PubMed ID: 36844956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.
    Stouten V; Pazmino S; Verschueren P; Mamouris P; Westhovens R; de Vlam K; Bertrand D; Van der Elst K; Vaes B; De Cock D
    RMD Open; 2021 Jun; 7(2):. PubMed ID: 34158353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical importance of the thyroid nodules during anti-tumor necrosis factor therapy in patients with axial spondyloarthritis.
    Terlemez R; Akgün K; Palamar D; Boz S; Sarı H
    Clin Rheumatol; 2017 May; 36(5):1071-1076. PubMed ID: 28357602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
    Sepriano A; Regel A; van der Heijde D; Braun J; Baraliakos X; Landewé R; Van den Bosch F; Falzon L; Ramiro S
    RMD Open; 2017; 3(1):e000396. PubMed ID: 28176964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus.
    Hammoudeh M; Abdulaziz S; Alosaimi H; Al-Rayes H; Aldeen Sarakbi H; Baamer M; Baraliakos X; Dahou Makhloufi C; Janoudi N; Shirazy K; Sieper J; Sukhbir U
    J Int Med Res; 2016 Apr; 44(2):216-30. PubMed ID: 26811411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
    Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
    Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why is biologic therapy useful in spondyloarthritis? Knowledge from synovial immunopathologic studies of spondyloarthritis.
    Chou CT
    Int J Rheum Dis; 2012 Dec; 15(6):507-11. PubMed ID: 23253232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical effects of anti-TNF-α agents in inflammatory diseases.
    Wendling D; Prati C
    Expert Rev Clin Immunol; 2014 Jan; 10(1):159-69. PubMed ID: 24325385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TNF therapy and malignancy in spondyloarthritis in the Leuven spondyloarthritis biologics cohort (BIOSPAR).
    Westhovens I; Lories RJ; Westhovens R; Verschueren P; de Vlam K
    Clin Exp Rheumatol; 2014; 32(1):71-6. PubMed ID: 24295201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
    Subramaniam K; Tymms K; Shadbolt B; Pavli P
    Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: Nonsteroidal Antiinflammatory Drug-Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR Cohort.
    Moltó A; Granger B; Wendling D; Breban M; Dougados M; Gossec L
    Arthritis Rheumatol; 2015 Sep; 67(9):2363-8. PubMed ID: 26109532
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.